Venous malformation is a congenital vascular malformation resulting from defective development during various stages of embryogenesis and selectively affecting the venous system. Depending on the embryologic stage when the developmental arrest occurred, the clinical presentation of venous malformation is extremely variable in location, extent, severity, natural progression, and hemodynamic impact. Extratruncular lesions occur in the earlier stages of embryonic life, and retain characteristics unique to mesenchymal cells (angioblasts), growing and proliferating when stimulated internally (eg, by menarche, pregnancy, and hormones) or externally (eg, by trauma or surgery). These lesions also have a significant hemodynamic impact on the venous system involved, in addition to the risk of localized intravascular coagulopathy. However, truncal lesions, as defective developments along the late stage, no longer carry the risk of proliferation and recurrence due to lack of mesenchymal characteristics. Although, they often have serious hemodynamic consequences due to direct involvement of the main vein trunk. Therefore, a thorough clinical history and careful physical examination should be followed by an appropriate combination of noninvasive and less invasive tests (eg, Doppler ultrasonography, magnetic resonance imaging, computed tomography) to confirm the clinical impression as well as to define the extent and severity of the venous malformation. Invasive tests, eg, phlebography or angiography, are seldom needed for the diagnosis per se. Additional evaluation for coagulation abnormalities, eg, D-dimer and fibrinogen levels, is generally recommended, especially for the treatment of surgery and endovascular candidates with extensive lesions to assess the localized intravascular coagulopathy status. Localized intravascular coagulopathy may cause serious thrombohemorrhagic events, including deep venous thrombosis and pulmonary embolism.
Introduction
Venous malformation is a congenital vascular malformation arising from defective development during various stages of embryogenesis selectively affecting the venous system. [1] [2] [3] [4] Venous malformation is often erroneously called "hemangioma", resulting in potentially serious mistakes in management. Indeed, during the last century, when there was insufficient knowledge about the condition, venous malformation (VM) was called hemangioma based on limited experience regarding vascular malformations and the fact that a rational classification concept was not established. Unfortunately, VM is still mistakenly described as "cystic/cavernous hemangioma" by physicians who are not familiar with the current terminology and literature. [5] [6] [7] Venous malformations and neonatal or infantile hemangioma [8] [9] [10] [11] [12] are as different as an apple and an orange. Hemangioma is a vascular tumor and not a congenital vascular malformation. Although congenital vascular malformations and hemangioma were classified together as "vascular anomalies" by the International Society for the Study of Vascular Anomalies classification 13, 14 to represent the entire group of anomalous vascular disorders, they are different not only in pathogenesis but also in clinical behavior.
Hemangioma originate from endothelial cells and have a distinct growth cycle characterized by a proliferation phase of early rapid growth followed by an involutional phase of slow regression. Unlike congenital vascular malformations, hemangiomas usually appear during the early neonatal period in perfectly normal neonates, but undergo self-limited growth and subsequent involution which is usually complete before the age of 5-10 years in the majority of cases ( Figure 1) .
In contrast, congenital VM and congenital vascular malformations in general [15] [16] [17] [18] exist at birth as an inborn error, although clinically not always obvious initially. The embryonic tissue remnants originate from the early stage of embryogenesis, never go away, but remain through the rest of life and maintain self-perpetual growth potential as an embryologic characteristic among the extratruncular lesions.
Depending on the embryologic stage when the developmental arrest has occurred, the clinical presentation of VM is extremely variable in location, extent, severity, and natural progress in addition to the hemodynamic impact (eg, marginal vein). [19] [20] [21] [22] Hence, diagnostics in patients with suspected VM mandate a proper understanding of embryologic and hemodynamic characteristics as well as adequate classification as one of many different congenital vascular malformations.
Definition and classification
Venous malformation, as one of the most common congenital vascular malformations, has been a source of confusion, with numerous names, including cavernous hemangioma, cavernous angioma, and phlebangioma. Many names have been based on the appearance of the anomaly, its anatomy, and its pathology, while other names have come from the clinicians who first described the lesion (eg, Klippel-Trenaunay syndrome), often resulting in redundant and confusing terminology. [23] [24] [25] [26] Today, VMs are defined according to the Hamburg classification as part of a large group of congenital vascular malformations, together with arterial, capillary, and lymphatic malformations ( Table 1 ).
Figure 1 (A)
Infantile hemangioma seen as a rapidly expanding lesion along the right cheek, first noted a few months after birth, which could be mistaken for a venous malformation. (B and C) Typical findings on magnetic resonance imaging of (infantile) hemangioma affecting the right cheek with prominent vascularity that helps differentiate it from a common vascular malformation. (D) Duplex ultrasonographic findings of active/high blood flow through the lesion in contrast with what would be found with a vascular malformation lesion. Note: Copyright © 2007. Phlebology. Lee Venous malformations are a result of defective development of the venous system during the two distinctly different stages of embryogenesis, and are further classified based on the embryologic stage when it developed, ie, extratruncular lesions (immature vascular network) and truncal lesions (mature vascular network). [27] [28] [29] [30] [31] [32] [33] [34] 
Extratruncular VM lesions
Extratruncular VM lesions (Table 1 ) are the outcome of defective development in earlier embryonic life when the vascular system is in the reticular stage before the main vascular trunks are formed. Therefore, these pretruncal embryonic lesions never involve the main trunk of the formed vein itself but remain as an independent "no-name" vascular structure separate from mature veins.
Extratruncular lesions retain unique characteristics of mesenchymal cells (angioblasts) as embryonic tissue remnants of mesodermal origin. They retain their potential to grow and proliferate when stimulated internally (eg, menarche, pregnancy, and hormones) or externally (eg, trauma, surgery). Hence, these lesions respond to various stimuli and proliferate, carrying a high risk of recurrence following incomplete treatment. Natural growth is usually slow and proportionate to the person's growth, and there is no spontaneous regression, as in hemangiomas. [27] [28] [29] [30] [31] [32] [33] [34] Depending on lesion size and location, VM lesions have a significant hemodynamic impact on the venous system involved, in addition to the risk of localized intravascular coagulopathy (LIC). Extratruncular VMs are further subdivided into diffuse infiltrating lesions and localized limited lesions to direct clinical management better. Diffuse infiltrating extratruncular VMs often cause symptoms due to compression of the surrounding structures, including muscles and nerves ( Figure 2 ).
Truncal VM lesions
Truncal VM lesions (Table 1 ) occur as defective development long after the primitive reticular stage of vascular development. Because the defective development occurs during the late stage when the vascular trunk is formed, these "posttruncal fetal lesions" no longer carry a risk of proliferation and recurrence due to lack of mesenchymal characteristics.
These lesions often have serious hemodynamic consequences due to direct involvement of the main vein trunk. In other words, all truncal lesions involve "named" vein trunks, eg, femoral, popliteal, and iliac veins. Truncal VM lesions manifest clinically as a defective main (or named) vein. Presentation ranges from incomplete or immature lesions (aplasia or hypoplasia) [35] [36] [37] to overdeveloped lesions (hyperplasia or aneurysm) [38] [39] [40] directly affecting the main axial veins in contrast with extratruncular lesions. [27] [28] [29] [30] [31] [32] [33] [34] Truncal lesions are further subdivided into obstructive [41] [42] [43] [44] or dilated [45] [46] [47] 
lesion types.
Avalvulia or avalvulosis (meaning absence of valves) is another form of congenital venous hypoplasia that produces venous reflux. Together with atresia of the lumens of venous trunks and venous aneurysms, these conditions are relatively common VMs. Another unique form of truncal VM is a fetal remnant (truncal) vessel as a persistent, large, embryonic vein, such as the marginal vein or the sciatic vein when a fetal (truncal) vessel fails to undergo normal involution. [48] [49] [50] [51] [52] Because these persistent fetal truncal vein remnants show no venous valves and the embryonic veins can be large, there is an associated risk of venous thromboembolism, especially when the condition is combined with consumptive coagulopathy, which is a common phenomenon with both extratruncular and truncal VMs (eg, the marginal vein, Figure 3 ).
Clinical evaluation
When VM lesions are present in superficial areas as localized bluish or purple lesions on the skin and mucosa, clinical examination is generally sufficient to make a correct clinical diagnosis. When present in a deep anatomic location, tissue, or organ, especially when asymptomatic, it is difficult to make a correct diagnosis by clinical examination alone.
The majority of VMs present with swelling and pain as the most common clinical findings and give a clue for further examination, and phleboliths detected on the plain soft tissue X-ray are a particularly good clue for VM with intraluminal venous stasis and subsequent thrombosis. Occasionally direct puncture needle aspiration of the lesion confirms the VM with the venous blood or rules it out with clear fluid/ lymph. Diagnosis of VM is not always easy, because it can mimic other congenital vascular malformations and even some malignant tumors. 53, 54 For proper clinical evaluation, a thorough clinical history is necessary as the first step in diagnostic evaluation because VM is one of a number of congenital vascular malformation lesions that can arise as a birth defect. Evaluation should include detailed information on presence of the lesion at birth, any subsequent change during life, triggers for rapid change such as puberty or trauma, and family history.
Appropriate physical examination should include careful assessment (inspection, palpation, auscultation) of both the arterial and venous systems, including a detailed pulse examination. Thorough inspection of the lesion, including the leg elevation shown in Figure 2B , should include evaluation for color, appearance, size, distribution, and localization of the lesion(s), as well as consistency on palpation and temperature ( Figure 2 ). Any edema, skin changes, varicosities, induration, pigmentation, thrombophlebitis, or ulceration suggestive of chronic venous insufficiency should be documented properly.
Physical examination should include detection of an enlarged or longer extremity, digital anomalies, and asymmetric growth of any part of the body. Pain (spontaneous or provoked) and tenderness should be assessed with proper documentation, in addition to auscultation for a possible bruit along the lesions.
Many VM lesions are associated with other congenital vascular malformations, especially lymphatic malformations. Therefore, special attention to cellulitis and lymphangitis is required during examination. VM with pelvic involvement may be associated with hematuria and rectal bleeding ( Figure 4 ). The appropriate combination of noninvasive (4):170-181. 20 and less invasive tests should follow in order to confirm the clinical impression as well as to define the extent and severity of the VM. [55] [56] [57] [58] [59] [60] [61] 
Noninvasive vascular investigations
Evaluation of VMs for diagnosis per se can be done in the majority of cases using noninvasive tests alone. Invasive tests can be reserved until needed as a road map for when treatment is performed.
Doppler ultrasonography
Doppler ultrasonography 1,62-65 remains the first step in evaluation of the hemodynamic status of any congenital vascular malformation and easily confirms the VM as a "slow flow" lesion. Doppler ultrasonography can also be helpful to distinguish the affected vessel type as being a slow flow malformation and differentiating between venous and lymphatic lesions.
VMs in subcutaneous or intramuscular tissues present as compressible hypoechogenic or anechogenic vascular spaces on B-mode ultrasound, while spectral Doppler demonstrates low flow status. Thrombosed lesions appear to be partially compressible or not compressible. Such features would allow correct differentiation of VMs from lymphatic malformations, which appear as noncompressible cystic spaces or arteriovenous malformations that demonstrate high flow. However, Doppler ultrasonography has a limited ability to assess involvement of adjacent structures, such as nerves and bone, and is less helpful in defining the extent of lesions not located in the extremities. Assessment of the feeding and draining vessels is best obtained by venography and/or varicography. For personal use only.
WBBPS (whole body blood pool scintigraphy)

Radionuclide lymphoscintigraphy TLPS (transarterial lung perfusion scintigraphy)
Magnetic resonance imaging
Together with Doppler ultrasonography, magnetic resonance imaging (MRI) 1,66-69 is the gold standard noninvasive diagnostic test for evaluation of VM lesions to verify the extent of the lesion. T2-weighted magnetic resonance images with and without contrast are not only able to confirm the nature of a congenital vascular malformation lesion such as VM with high signal intensity but are also able to provide detailed information on its extent and severity, in addition to its relationship with adjacent or underlying tissues. Phleboliths as a hallmark of VM lesions appear as low-signal or void on T1-weighted and T2-weighted MRI images (Figure 4 ). Initial assessment of the VM using MRI (fat saturated T2-weighted imaging) with no contrast is now fully accepted as a routine part of the initial investigation. MRI with no contrast is recommended for follow-up assessment of natural progression as well as to monitor the therapeutic response, at mean 2-3-year intervals unless otherwise indicated.
MRI with contrast (angiography and venography) is indicated to differentiate mixed conditions of VM and lymphatic malformation. Magnetic resonance venography may be more helpful for assessment of the therapeutic outcome in complex forms of VM, and may be most helpful for assessment of the entire infradiaphragmatic venous system altogether at the same time.
Computed axial tomography
Advanced computed tomography (CT) diagnostics can provide more information on congenital vascular malformations than MRI, especially when the test is combined with contrast. Newly developed 64-slice spiral CT angiography can visualize the extent of a VM lesion, and the relationship with adjacent vessel, muscle, and bone structures more clearly from multiple angles in three dimensions. [70] [71] [72] [73] Additional information on the skeletal system together with the soft tissue is more advantageous than standard MRI. However, arteriovenous malformations will get the most benefit from CT angiography with three-dimensional reconstruction regarding the extent of the lesion and its relationship with surrounding structures. CT angiography is valuable for assessment of complicated congenital vascular malformations, especially postoperative or postexcisional recurrence.
Whole body blood pool scintigraphy
Whole body blood pool scintigraphy [74] [75] [76] [77] is an optional test for diagnosis of VM in general, and excellent when screening for further VM lesions because it is able to detect 1.0 mL of abnormal blood pooling throughout the body. Therefore, whole body blood pool scintigraphy is the safest, easiest, and cheapest method for general assessment of VM (multifocal lesions), for follow-up assessment after therapy sessions, as well as follow-up of the natural course. This technique is also excellent for ruling out a lymphatic malformation that is sometimes hard to differentiate based on MRI alone (Figure 4 ).
Transarterial lung perfusion scintigraphy
Transarterial lung perfusion scintigraphy 1, 13, 78 is also one of the optional tests and the most accurate way of assessing arteriovenous malformations located along an extremity, and is sensitive enough to detect microfistulous shunting that arteriography might fail to detect (eg, a microshunting arteriovenous malformation). Therefore, transarterial lung perfusion scintigraphy remains a crucial test either to rule out a hidden microfistulous arteriovenous malformation as part of Parkes-Weber syndrome or to confirm the condition as Klippel-Trenaunay syndrome by ruling out hidden arteriovenous malformations [79] [80] [81] (Figure 4) . Because of the need for cumbersome arterial puncture, its clinical use in VM diagnostics has been limited to specific indications.
Radionuclide lymphoscintigraphy
Radionuclide lymphoscintigraphy 82-85 has a limited role in the diagnosis of VM, but is the only specific test for assessment of the lymphatic system, and remains essential to confirm as well as assess the extent of truncal lymphatic malformation involved in Klippel-Trenaunay syndrome as primary lymphedema together with VM lesions. [86] [87] [88] [89] Therefore, it is a mandatory test for hemolymphatic malformation, 1, 13 a combined form of VM, for assessment of lymphatic function. Interpretation of the results should be extended from clearance rate to the general status of lymph vessels and nodes, including dermal backflow (Figure 4 ).
Conventional soft tissue plain radiography
The standard plain X-ray remains essential in the management of VM to assess for phleboliths as a possible cause of aching and/or pain. It remains useful for identifying abnormalities in the soft tissue and malformation-related abnormalities in the skeletal system other than phleboliths. 90, 91 It is routinely indicated for assessment of adjacent skeletal anomalies and overgrowth, eg, vascular bone syndrome, especially in patients with Klippel-Trenaunay syndrome, and confirmation of phleboliths as extra evidence of coagulopathy in VM lesions. 92, 93 Bone scanography Scanograms are long bone radiographs that provide an accurate measurement of long bone length. This test is essential when assessing for any discrepancy in bone length involving the upper or lower limbs. Therefore, any VM or congenital vascular malformation combining abnormal long bone growth with a discrepancy in leg/arm length should have a baseline scanographic measurement repeated every two years until bone growth is complete. The assessment should be extended to include evaluation for pelvic tilt and compensatory scoliosis. Documentation of this would become an objective criterion for further management. 94, 95 Other noninvasive studies, such as plethysmography, segmental pressure measurement, and pulse volume recordings can be used selectively based on clinical correlations with the abnormal findings (eg, outflow obstruction) which need to be assessed.
Invasive vascular tests
Invasive tests 1, 13, 96, 97 are seldom needed to establish the diagnosis of VM and can be deferred until intervention is required. Conventional venography and/or percutaneous direct puncture phlebography are generally indicated for planning of treatment, which may be surgical or endovascular. However, invasive tests may be required for diagnosis when noninvasive tests (eg, CT and/or MRI) fail to confirm the diagnosis or delineate important diagnostic details. These tests include: ascending, descending, and/or segmental venography or phlebography; standard and/or selective arteriography; percutaneous direct puncture angiography, ie, arteriography or phlebography; and varicography or lymphography.
Ascending phlebography with or without application of a compression bandage is needed as a part of the road map when therapy is indicated for VM lesions affecting the lower extremity. When combined with intravenous ultrasonography, more precise anatomic information can be provided for an obstructive truncal VM lesion along the iliac vein, ie, the exact dimensions of venous obstructions or aneurysms.
Descending phlebography with or without the Valsalva test is indispensable for truncal VM with chronic venous insufficiency to assess for deep venous reflux along the pelvic veins and/or sciatic veins. These studies are often required as a road map for subsequent embolo/sclerotherapy.
Direct puncture percutaneous phlebography is indicated for all extratruncular VM lesions as a road map for treatment to verify the size and extent of the lesion together with the status of draining veins. It is quite useful for identifying large draining veins from VM lesions for subsequent embolo/sclerotherapy with a reduced risk of recurrence ( Figure 3B ).
VM and coagulopathy
Coagulation abnormalities are common in patients with VM lesions (42%) especially in those with extensive lesions involving a large surface area and deep tissue structures. Coagulation abnormalities occurring in VMs are due to LIC [98] [99] [100] [101] and are different from those seen in Kasabach-Merritt syndrome. [102] [103] [104] [105] Kasabach-Merritt syndrome, which develops only in the hemangioma/vascular tumor, is a hallmark of coagulopathy. It is initiated by platelet trapping within a vascular tumor that develops in infancy. However, LIC associated with the VM lesion is a distinctive, lifelong consumptive coagulopathy precipitated by blood stagnation within the VM lesion resulting in thrombosis and subsequent phlebolith formation. Therefore, palpable phleboliths and an elevated D-dimer level remain the hallmarks of LIC in patients with VM.
LIC is characterized by a decrease in fibrinogen, an increase in D-dimer levels, and the presence of soluble fibrin complexes. Platelet counts are normal or slightly decreased, but generally accompanies mild reduction of the platelet count due to the increased consumption. LIC is more likely associated with large and/or deep VM lesions of any location and may present with palpable phleboliths on examination. These patients are often found to have elevated D-dimer levels combined with low fibrinogen levels and commonly present with a VM lesion involving an extremity.
LIC may cause serious thrombohemorrhagic events, including deep venous thrombosis and pulmonary embolism. LIC can also cause disseminated intravascular coagulopathy with life-threatening hemorrhage. A number of events, including sclerotherapy, surgical resection, bone fracture, prolonged immobilization, pregnancy, and menstruation are known to trigger the conversion of LIC to disseminated intravascular coagulopathy, with bleeding related to factor consumption and multiorgan failure related to disseminated microvascular thrombosis. 103, [106] [107] [108] [109] Clinical symptoms associated with worsening of LIC are pain, thrombosis, and bleeding at wound sites during surgery. In severe forms, bleeding can occur, causing painful hematomas within the VM, hemarthrosis in patients with joint involvement, or bleeding outside the area of the VM. 103 Patients with extensive VMs or high-risk lesions should undergo the following laboratory tests: a full blood count including hemoglobin levels and platelet count; a quantitative submit your manuscript | www.dovepress.com
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Journal of Vascular Diagnostics and Interventions downloaded from https://www.dovepress.com/ by 54.70.40.11 on 31-Jan-2020 For personal use only. D-dimer assay; fibrinogen level; and prothrombin time, activated partial thromboplastin time, and coagulation profile (optional). Measurement of hemoglobin and platelet counts are especially recommended to exclude chronic blood loss from VMs involving the gastrointestinal tract.
It is important to obtain an accurate diagnostic algorithm for coagulopathies associated with VM to guide appropriate management of these potentially life-threatening disorders. Measurement of D-dimer and fibrinogen levels should be included in the baseline laboratory evaluation of all patients with VM.
Histopathology
A biopsy should be performed whenever diagnosis remains doubtful for the differential diagnosis with malignant tumor in particular besides a noninvoluting vascular tumor such as a noninvoluting congenital hemangioma level. [110] [111] [112] These lesions have high flow on Doppler and persist indefinitely, and may be confused with an arteriovenous malformation. Conclusive genetic tests can be useful to assess rare inherited forms of VM.
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